Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam Aguas

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Therapeutic Advances in Gastroenterology|May 14, 2025
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort studyIago Rodríguez-Lago, Urko M Marigorta, Beatriz Mateos, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkersMontse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomicsMacarena Orejudo, Manuel J Gómez, Sabino Riestra, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA RegistryLucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Frontiers in Medicine|February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native PatientsAna Gutiérrez, Pedro Zapater, Elena Ricart, et al.
Journal of Clinical Medicine|October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine|July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological StudyMaría Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Therapeutic Advances in Gastroenterology|May 14, 2025
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort studyIago Rodríguez-Lago, Urko M Marigorta, Beatriz Mateos, et al.
Journal of Crohn'S & Colitis|October 9, 2025
Comprehensive proteomic profile in newly diagnosed patients with inflammatory bowel disease: identification of potential biomarkersMontse Baldán-Martín, Ibon Iloro, Mikel Azkargorta, et al.
Inflammatory Bowel Diseases|August 3, 2023
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease PatientsLaila Aldars-García, Rubén Gil-Redondo, Nieves Embade, et al.
Frontiers in Cellular and Infection Microbiology|July 16, 2025
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomicsMacarena Orejudo, Manuel J Gómez, Sabino Riestra, et al.
Therapeutic Advances in Gastroenterology|February 24, 2026
Hidradenitis suppurativa in patients with inflammatory bowel disease: a national multicenter study from the GETECCU-ENEIDA RegistryLucía Madero-Velázquez, Ruth de Francisco, Belen Herreros, et al.
Therapeutic Advances in Gastroenterology|January 8, 2024
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registryMargalida Calafat, Paola Torres, Joan Tosca-Cuquerella, et al.
Alimentary Pharmacology & Therapeutics|June 10, 2026
Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA RegistryManuel Barreiro-de Acosta, Yamile Zabana, Laura Nieto-García, et al.
Frontiers in Medicine|February 18, 2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native PatientsAna Gutiérrez, Pedro Zapater, Elena Ricart, et al.
Journal of Clinical Medicine|October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine|July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological StudyMaría Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Pageof 6